Stakeholder Engagement Session on the Third Legislative Review of the Tobacco and Vaping Products Act – August 14, 2025

Subject(s)

Consultation Session on the Third Legislative Review of the Tobacco and Vaping Products Act

Date

August 14, 2025

Participants

Tobacco Control Directorate

Industry Representatives

Introduction

The Tobacco Control Directorate (TCD) invited vaping industry representatives to a consultation session on the third legislative review of the Tobacco and Vaping Products Act (TVPA). On June 27, 2025, the Government of Canada launched a public consultation to solicit feedback on compliance and enforcement challenges identified in the previous two legislative reviews, such as a potential need for additional or enhanced tools for a progressive enforcement approach.

TCD reminded participants that this meeting is subject to disclosure as per Health Canada's Openness and Transparency policies. The handling of information and privacy notice was outlined and acknowledged.

Health Canada also referred to Article 5.3 of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC), its international obligation to protect tobacco control policies from the vested interests of the tobacco industry.

Subjects

TCD welcomed participants and stated the objective of the consultation session was to provide participants with additional details on the third legislative review of the TVPA and discussion questions for their consideration when providing their formal written submissions. In addition, TCD sought to collect the views of industry on challenges they feel they face complying with the TVPA.

TCD gave a presentation describing the approach to the third legislative review of the TVPA and the three themes identified for the review—the changing market, regulating in a digital era, and facilitating collaboration through the legislative framework of the TVPA—and spoke to some of the challenges Health Canada is facing with regard to compliance and enforcement of the TVPA in these areas. TCD also set out next steps and information on how to participate in the consultation and contribute to the review.

Health Canada then opened the floor to questions.

Age verification processes

Industry representatives suggested that requiring photo ID to verify the age and identity of visitors to retailer or manufacturer websites that contain vaping advertising is invasive and asked whether Health Canada would change its position on this issue to accept self-attestation methods such as checking a box or providing a birthdate.

Illicit market

Industry representatives sought further information on enforcement efforts related to the illicit market.

Contraventions

Industry representatives asked when they would be made aware of which specific vaping-related offences in the TVPA and/or associated regulations will be designated as contraventions under the Contraventions Act.

Compliance promotion

Industry representatives sought further information on what measures Health Canada can take to provide additional guidance to small businesses in Canada to help them comply with the TVPA and associated regulations.

Industry representatives asked whether Health Canada planned to develop a standardized industry guidance document on vaping flavour name conventions.

Resources

Industry representatives asked whether Health Canada could request additional resources to support enforcement efforts.

Comparative health statements

Industry representatives sought further information on the development and implementation of an authorized, evidence-based list of comparative health statements to be used in adult-only settings to help adult smokers make informed choices.

Seizures of non-compliant products

Industry representatives asked whether Health Canada has the authority to seize non-compliant vaping products and how many products Health Canada has removed from the market.

Prioritization of compliance and enforcement efforts

Industry representatives ask Health Canada to prioritize compliance and enforcement efforts on products that have a greater impact on the public, such as those exceeding the maximum nicotine concentration limit.

Regulatory development

Industry representatives noted that there has been a rapid succession of new vaping regulations since 2018 and asked what Health Canada will do to provide regulatory stability, with reasonable transition periods for industry members.

Industry representatives asked when the new Forward Regulatory Plan would be published.

Ingredient reports

Industry representatives asked how Health Canada verifies it receives ingredient reports from all importers and manufacturers.

Reporting potential violations

Industry representatives asked how to report potential violations of the TVPA to Health Canada.

In closing, Health Canada thanked participants for their time and encouraged them to contribute to the legislative review by sending a written submission to the Legislative Review Secretariat.

Conclusion

The meeting was then concluded.

Documents

Page details

2026-01-09